{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:55:57Z","timestamp":1792184157970,"version":"4.4.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.freeradbiomed.2016.10.490","type":"journal-article","created":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T16:17:00Z","timestamp":1477325820000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":244,"special_numbering":"C","title":["Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders"],"prefix":"10.1016","volume":"111","author":[{"given":"Fabio","family":"Di Domenico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tramutola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3C","key":"10.1016\/j.freeradbiomed.2016.10.490_bib1","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1016\/0002-9343(91)90281-2","article-title":"Oxidative stress: from basic research to clinical application","volume":"91","author":"Sies","year":"1991","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1566-3124(08)60057-7","article-title":"Protein oxidation processes in aging brain","volume":"2","author":"Butterfield","year":"1997","journal-title":"Adv. Cell Aging Gerontol."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib4","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archneur.56.12.1449","article-title":"The role of oxidative stress in Alzheimer disease","volume":"56","author":"Markesbery","year":"1999","journal-title":"Arch. Neurol."},{"issue":"7113","key":"10.1016\/j.freeradbiomed.2016.10.490_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0891-5849(91)90192-6","article-title":"Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes","volume":"11","author":"Esterbauer","year":"1991","journal-title":"Free Radic. Biol. Med."},{"issue":"4\u20135","key":"10.1016\/j.freeradbiomed.2016.10.490_bib7","first-page":"315","article-title":"4-Hydroxynonenal in the pathomechanisms of oxidative stress","volume":"50","author":"Poli","year":"2000","journal-title":"IUBMB Life"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0005-2760(80)90209-X","article-title":"Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids","volume":"620","author":"Benedetti","year":"1980","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0005-2760(82)90044-3","article-title":"Evidence for aldehydes bound to liver microsomal protein following CCl4 or BrCCl3 poisoning","volume":"711","author":"Benedetti","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/bj2140479","article-title":"Effects of 4-hydroxynonenal on isolated hepatocytes. Studies on chemiluminescence response, alkane production and glutathione status","volume":"214","author":"Cadenas","year":"1983","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0005-2760(84)90219-4","article-title":"Cytotoxic aldehydes originating from the peroxidation of liver microsomal lipids. Identification of 4,5-dihydroxydecenal","volume":"792","author":"Benedetti","year":"1984","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1042\/bj2280363","article-title":"Metabolism of the lipid peroxidation product 4-hydroxynonenal by isolated hepatocytes and by liver cytosolic fractions","volume":"228","author":"Esterbauer","year":"1985","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0891-5849(89)90113-5","article-title":"Lipid peroxidation in human diseases: evidence of red cell oxidative stress after circulatory shock","volume":"6","author":"Poli","year":"1989","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1471-4159.1997.68010255.x","article-title":"A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide","volume":"68","author":"Mark","year":"1997","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0197-4580(98)00009-8","article-title":"Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease","volume":"19","author":"Markesbery","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib16","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1046\/j.1471-4159.1997.69031161.x","article-title":"The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins","volume":"69","author":"Subramaniam","year":"1997","journal-title":"J. Neurochem."},{"issue":"5134","key":"10.1016\/j.freeradbiomed.2016.10.490_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.7901908","article-title":"Oxidative stress, glutamate, and neurodegenerative disorders","volume":"262","author":"Coyle","year":"1993","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.10.490_bib18","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.freeradbiomed.2011.06.027","article-title":"Lipid peroxidation and neurodegenerative disease","volume":"51","author":"Reed","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"4\u20135","key":"10.1016\/j.freeradbiomed.2016.10.490_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0098-2997(03)00024-4","article-title":"4-hydroxynonenal and neurodegenerative diseases","volume":"24","author":"Zarkovic","year":"2003","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/ars.1999.1.3-339","article-title":"Oxidation-dependent changes in the stability and permeability of lipid bilayers","volume":"1","author":"Anzai","year":"1999","journal-title":"Antioxid. Redox Signal."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib21","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0197-4580(02)00074-X","article-title":"The role of polyunsaturated fatty acids in restoring the aging neuronal membrane","volume":"23","author":"Yehuda","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1471-4159.2001.00451.x","article-title":"The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42","volume":"78","author":"Lauderback","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib23","first-page":"1798","article-title":"Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Abeta accumulation in AD brain","volume":"49","author":"Owen","year":"2010"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib24","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.bbadis.2015.01.015","article-title":"On the role of 4-hydroxynonenal in health and disease","volume":"1852","author":"Csala","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.10.490_bib25","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.3109\/10715762.2010.498477","article-title":"Chemistry and biochemistry of lipid peroxidation products","volume":"44","author":"Gueraud","year":"2010","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.redox.2013.01.007","article-title":"The lipid peroxidation product 4-hydroxy-2-nonenal: advances in chemistry and analysis","volume":"1","author":"Spickett","year":"2013","journal-title":"Redox Biol."},{"issue":"32","key":"10.1016\/j.freeradbiomed.2016.10.490_bib27","doi-asserted-by":"crossref","first-page":"21837","DOI":"10.1074\/jbc.R700019200","article-title":"Oxidative stress and covalent modification of protein with bioactive aldehydes","volume":"283","author":"Grimsrud","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.10.490_bib28","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1089\/ars.2011.4406","article-title":"4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies","volume":"17","author":"Perluigi","year":"2012","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fphys.2013.00242","article-title":"Interaction of aldehydes derived from lipid peroxidation and membrane proteins","volume":"4","author":"Pizzimenti","year":"2013","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0197-4580(01)00340-2","article-title":"Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death","volume":"23","author":"Butterfield","year":"2002","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib31","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.nbd.2013.09.018","article-title":"The Janus face of the heme oxygenase\/biliverdin reductase system in Alzheimer disease: it's time for reconciliation","volume":"62","author":"Barone","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib32","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0005-2760(86)90329-2","article-title":"Studies on the mechanism of formation of 4-hydroxynonenal during microsomal lipid peroxidation","volume":"876","author":"Esterbauer","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0076-6879(90)86093-B","article-title":"Role of free radicals and catalytic metal ions in human disease: an overview","volume":"186","author":"Halliwell","year":"1990","journal-title":"Methods Enzymol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/gps.1469","article-title":"Decreased plasma antioxidants in patients with Alzheimer's disease","volume":"21","author":"Kim","year":"2006","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.freeradbiomed.2012.09.027","article-title":"Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain","volume":"62","author":"Sultana","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.2174\/09298673113209990181","article-title":"4-Hydroxynonenal in the pathogenesis and progression of human diseases","volume":"21","author":"Shoeb","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.10.490_bib37","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2174\/0929867043365323","article-title":"Oxidative stress and cell signalling","volume":"11","author":"Poli","year":"2004","journal-title":"Curr. Med. Chem."},{"issue":"Pt 3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib38","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem. J."},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2016.10.490_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0169-328X(00)00234-5","article-title":"The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons","volume":"85","author":"Camandola","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.nbd.2007.11.004","article-title":"Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease","volume":"29","author":"Bader Lange","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2016.10.490_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.brainres.2004.01.036","article-title":"Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease","volume":"1004","author":"Castegna","year":"2004","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1179\/135100007X162167","article-title":"Modulation of antioxidant gene expression by 4-hydroxynonenal: atheroprotective role of the Nrf2\/ARE transcription pathway","volume":"12","author":"Siow","year":"2007","journal-title":"Redox Rep.: Commun. Free Radic. Res."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.10.490_bib43","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.bbalip.2010.02.005","article-title":"Involvements of the lipid peroxidation product, HNE, in the pathogenesis and progression of Alzheimer's disease","volume":"1801","author":"Butterfield","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib44","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1021\/tx960130e","article-title":"Beta-Amyloid-associated free radical oxidative stress and neurotoxicity: implications for Alzheimer's disease","volume":"10","author":"Butterfield","year":"1997","journal-title":"Chem. Res. Toxicol."},{"issue":"11\u201312","key":"10.1016\/j.freeradbiomed.2016.10.490_bib45","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1089\/ars.2006.8.1971","article-title":"Oxidative stress in neurodegenerative disorders","volume":"8","author":"Butterfield","year":"2006","journal-title":"Antioxid. Redox Signal."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.10.490_bib46","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1089\/ars.2011.4109","article-title":"Redox proteomics in selected neurodegenerative disorders: from its infancy to future applications","volume":"17","author":"Butterfield","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/mas.21374","article-title":"Mass spectrometry and redox proteomics: applications in disease","volume":"33","author":"Butterfield","year":"2014","journal-title":"Mass Spectrom. Rev."},{"issue":"4\u20135","key":"10.1016\/j.freeradbiomed.2016.10.490_bib48","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000176417","article-title":"Autoantibodies to oxidized low density lipoproteins in restenosis following coronary angioplasty","volume":"84","author":"Eber","year":"1994","journal-title":"Cardiology"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib49","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/1567205013666151218131424","article-title":"Autoantibodies profile in matching CSF and serum from AD and aMCI patients: potential pathogenic role and link to oxidative damage","volume":"13","author":"Di Domenico","year":"2016","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jalz.2015.02.003","article-title":"Alzheimer's disease facts and figures","volume":"11","author":"Alzheimer's","year":"2015","journal-title":"Alzheimers Dement"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib51","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib52","doi-asserted-by":"crossref","first-page":"756357","DOI":"10.1100\/2012\/756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.10.490_bib53","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib54","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol. Med."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib55","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.freeradbiomed.2007.05.037","article-title":"Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment","volume":"43","author":"Butterfield","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.10.490_bib56","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2174\/187152707783399201","article-title":"Neuronal death and survival under oxidative stress in Alzheimer and Parkinson diseases","volume":"6","author":"Nunomura","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib57","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1021\/tx049796w","article-title":"Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity","volume":"17","author":"Boyd-Kimball","year":"2004","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2004.12.022","article-title":"Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease","volume":"132","author":"Boyd-Kimball","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/0-387-23226-5_8","article-title":"Amyloid accumulation and pathogensis of Alzheimer's disease: significance of monomeric, oligomeric and fibrillar Abeta","volume":"38","author":"Glabe","year":"2005","journal-title":"Subcell. Biochem."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib60","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3233\/JAD-2006-10407","article-title":"Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer's disease: an initial assessment","volume":"10","author":"Butterfield","year":"2006","journal-title":"J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib61","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/PL00000660","article-title":"4-Hydroxynonenal-modified amyloid-beta peptide inhibits the proteasome: possible importance in Alzheimer's disease","volume":"57","author":"Shringarpure","year":"2000","journal-title":"Cell Mol. Life Sci."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib62","first-page":"845","article-title":"Oxidative stress and amyloidosis","volume":"13","author":"Ando","year":"1998","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib63","article-title":"Poly-Ubiquitinylation Profile in Down Syndrome Brain before and after the Development of Alzheimer Neuropathology","author":"Tramutola","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib64","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nbdi.2002.0515","article-title":"Oxidative stress increases expression and activity of BACE in NT2 neurons","volume":"10","author":"Tamagno","year":"2002","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib65","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1471-4159.2004.02895.x","article-title":"Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways","volume":"92","author":"Tamagno","year":"2005","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib66","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1474-9726.2012.00817.x","article-title":"Oxidative lipid modification of nicastrin enhances amyloidogenic gamma-secretase activity in Alzheimer's disease","volume":"11","author":"Gwon","year":"2012","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib67","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbapap.2004.10.014","article-title":"The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity","volume":"1703","author":"Butterfield","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"24","key":"10.1016\/j.freeradbiomed.2016.10.490_bib68","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1021\/ja010452r","article-title":"Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1\u201342) and A beta(25\u201335)","volume":"123","author":"Varadarajan","year":"2001","journal-title":"J. Am. Chem. Soc."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.10.490_bib69","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0891-5849(02)00821-3","article-title":"Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide","volume":"32","author":"Kanski","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"49","key":"10.1016\/j.freeradbiomed.2016.10.490_bib70","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1021\/bi201426b","article-title":"Induction of methionine-sulfoxide reductases protects neurons from amyloid beta-protein insults in vitro and in vivo","volume":"50","author":"Moskovitz","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib71","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0070-2153(07)80003-2","article-title":"Substrates of the methionine sulfoxide reductase system and their physiological relevance","volume":"80","author":"Oien","year":"2008","journal-title":"Curr. Top. Dev. Biol."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.10.490_bib72","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/00005072-199708000-00004","article-title":"4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease","volume":"56","author":"Montine","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0197-4580(97)00108-5","article-title":"Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease","volume":"18","author":"Lovell","year":"1997","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib74","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005072-199602000-00009","article-title":"Crosslinking of apolipoprotein E by products of lipid peroxidation","volume":"55","author":"Montine","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-8993(01)03228-0","article-title":"Apolipoprotein E modulates Alzheimer's Abeta(1-42)-induced oxidative damage to synaptosomes in an allele-specific manner","volume":"924","author":"Lauderback","year":"2002","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2003.11.047","article-title":"4-Hydroxynonenal oxidatively modifies histones: implications for Alzheimer's disease","volume":"356","author":"Drake","year":"2004","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib77","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00005072-199803000-00007","article-title":"4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats","volume":"57","author":"Bruce-Keller","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"9","key":"10.1016\/j.freeradbiomed.2016.10.490_bib78","first-page":"485","article-title":"Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde","volume":"94","author":"McGrath","year":"2001","journal-title":"Qjm-Mon. J. Assoc. Phys."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib79","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(01)00327-X","article-title":"The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease","volume":"23","author":"Selley","year":"2002","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.10.490_bib80","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bbadis.2008.07.008","article-title":"Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease","volume":"1782","author":"Aluise","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.10.490_bib81","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0891-5849(02)01049-3","article-title":"Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients","volume":"33","author":"Cecchi","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.10.490_bib82","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.freeradbiomed.2004.05.028","article-title":"Oxidative stress impairs glutamate uptake in fibroblasts from patients with alzheimer's disease","volume":"37","author":"Begni","year":"2004","journal-title":"Free Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.10.490_bib83","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.WNL.0000156156.13641.BA","article-title":"Evidence of increased oxidative damage in subjects with mild cognitive impairment","volume":"64","author":"Keller","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib84","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.neulet.2005.12.017","article-title":"Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment","volume":"397","author":"Butterfield","year":"2006","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.freeradbiomed.2016.10.490_bib85","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/prca.200800161","article-title":"Redox proteomics identification of 4-hydroxynonenal-modified brain proteins in Alzheimer's disease: role of lipid peroxidation in Alzheimer's disease pathogenesis","volume":"3","author":"Perluigi","year":"2009","journal-title":"Proteom. Clin. Appl."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.nbd.2007.12.007","article-title":"Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease","volume":"30","author":"Reed","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib87","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2009.04.009","article-title":"Proteomic identification of HNE-bound proteins in early Alzheimer disease: insights into the role of lipid peroxidation in the progression of AD","volume":"1274","author":"Reed","year":"2009","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib88","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.autrev.2010.07.008","article-title":"Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression","volume":"9","author":"Colasanti","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib89","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.freeradbiomed.2015.12.012","article-title":"Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: a new paradigm","volume":"91","author":"Barone","year":"2016","journal-title":"Free Radic. Biol. Med."},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2016.10.490_bib90","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/prca.201200087","article-title":"Apolipoprotein A-I: insights from redox proteomics for its role in neurodegeneration","volume":"7","author":"Keeney","year":"2013","journal-title":"Proteom. Clin. Appl."},{"issue":"11\u201312","key":"10.1016\/j.freeradbiomed.2016.10.490_bib91","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.freeradbiomed.2012.03.020","article-title":"Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment","volume":"52","author":"Barone","year":"2012","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib92","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbadis.2011.01.005","article-title":"Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment","volume":"1812","author":"Barone","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib93","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-2011-110092","article-title":"Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment","volume":"25","author":"Barone","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib94","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.brainres.2010.11.067","article-title":"Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice","volume":"1371","author":"Kurata","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib95","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.redox.2013.01.002","article-title":"Oxidative modification of lipoic acid by HNE in Alzheimer disease brain","volume":"1","author":"Hardas","year":"2013","journal-title":"Redox Biol."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lfs.2014.11.021","article-title":"Orientin alleviates cognitive deficits and oxidative stress in Abeta1-42-induced mouse model of Alzheimer's disease","volume":"121","author":"Yu","year":"2015","journal-title":"Life Sci."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib97","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuro.2013.07.007","article-title":"Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats","volume":"38","author":"Zhou","year":"2013","journal-title":"Neurotoxicology"},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2016.10.490_bib98","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","article-title":"Metals, oxidative stress and neurodegenerative disorders","volume":"345","author":"Jomova","year":"2010","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib99","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s007020050002","article-title":"Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders","volume":"107","author":"Kruger","year":"2000","journal-title":"J. Neural Transm."},{"issue":"8","key":"10.1016\/j.freeradbiomed.2016.10.490_bib100","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1194\/jlr.M600003-JLR200","article-title":"Interactions between fatty acids and alpha-synuclein","volume":"47","author":"Lucke","year":"2006","journal-title":"J. Lipid Res."},{"issue":"26","key":"10.1016\/j.freeradbiomed.2016.10.490_bib101","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1021\/bi052584t","article-title":"Alpha-synuclein can function as an antioxidant preventing oxidation of unsaturated lipid in vesicles","volume":"45","author":"Zhu","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib102","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.freeradbiomed.2013.01.003","article-title":"Oxidative damage to macromolecules in human Parkinson disease and the rotenone model","volume":"62","author":"Sanders","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"11","key":"10.1016\/j.freeradbiomed.2016.10.490_bib103","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1089\/ars.2011.4312","article-title":"Redox proteomics analyses of the influence of co-expression of wild-type or mutated LRRK2 and Tau on C. elegans protein expression and oxidative modification: relevance to Parkinson disease","volume":"17","author":"Di Domenico","year":"2012","journal-title":"Antioxid. Redox Signal."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib104","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","article-title":"Role of oxidative stress in Parkinson's disease","volume":"22","author":"Hwang","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease","volume":"106\u2013107","author":"Subramaniam","year":"2013","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib107","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","article-title":"Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease","volume":"142","author":"Sofic","year":"1992","journal-title":"Neurosci. Lett."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib108","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nchembio782","article-title":"Elevated levels of oxidized cholesterol metabolites in Lewy body disease brains accelerate alpha-synuclein fibrilization","volume":"2","author":"Bosco","year":"2006","journal-title":"Nat. Chem. Biol."},{"issue":"8507","key":"10.1016\/j.freeradbiomed.2016.10.490_bib109","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(86)92471-2","article-title":"Lipid-peroxidation as cause of nigral cell-death in Parkinsons-disease","volume":"2","author":"Dexter","year":"1986","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.10.490_bib110","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1073\/pnas.93.7.2696","article-title":"Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease","volume":"93","author":"Yoritaka","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib112","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurobiolaging.2006.10.022","article-title":"Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases","volume":"29","author":"Dalfo","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib113","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0891-5849(98)00021-5","article-title":"(E)-4-hydroxy-2-nonenal may be involved in the pathogenesis of Parkinson's disease","volume":"25","author":"Selley","year":"1998","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib114","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nbd.2010.07.010","article-title":"Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice","volume":"40","author":"Melrose","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib115","article-title":"Rotenone induces the formation of 4-hydroxynonenal aggresomes. Role of ROS-mediated tubulin hyperacetylation and autophagic flux disruption","author":"Bonet-Ponce","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib116","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/10715762.2015.1005085","article-title":"LC\/MS analysis of cardiolipins in substantia nigra and plasma of rotenone-treated rats: implication for mitochondrial dysfunction in Parkinson's disease","volume":"49","author":"Tyurina","year":"2015","journal-title":"Free Radic. Res."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib117","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.toxlet.2011.07.020","article-title":"Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease","volume":"207","author":"Shchepinov","year":"2011","journal-title":"Toxicol. Lett."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib118","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib119","first-page":"16","article-title":"Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib122","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","article-title":"PGC-1alpha, mitochondrial dysfunction, and Huntington's disease","volume":"62","author":"Johri","year":"2013","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib123","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain Pathol."},{"issue":"3","key":"10.1016\/j.freeradbiomed.2016.10.490_bib124","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","article-title":"Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice","volume":"121","author":"Lee","year":"2011","journal-title":"Acta Neuropathol."},{"issue":"12","key":"10.1016\/j.freeradbiomed.2016.10.490_bib126","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteom."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib127","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1471-4159.2001.00417.x","volume":"78","author":"Lee","year":"2001","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.10.490_bib128","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0891-5849(02)01080-8","article-title":"Do oxidatively modified proteins cause als?","volume":"33","author":"Valentine","year":"2002","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2014.03.027","article-title":"Redox proteomics analysis of HNE-modified proteins in Down syndrome brain: clues for understanding the development of Alzheimer disease","volume":"71","author":"Di Domenico","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2016.10.490_bib130","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0079-6123(08)61151-6","article-title":"Reactions of nitric-oxide, superoxide and peroxynitrite with superoxide-dismutase in neurodegeneration","volume":"103","author":"Beckman","year":"1994","journal-title":"Prog. Brain Res."},{"issue":"15","key":"10.1016\/j.freeradbiomed.2016.10.490_bib131","first-page":"221","article-title":"Mutations in SOD1 and FUS caused juvenile-onset sporadic amyotrophic lateral sclerosis with aggressive progression","volume":"3","author":"Zou","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"1\u20132","key":"10.1016\/j.freeradbiomed.2016.10.490_bib132","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbrc.2015.05.027","article-title":"4-Hydroxynonenal induces persistent insolubilization of TDP-43 and alters its intracellular localization","volume":"463","author":"Kabuta","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib133","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/ana.410440518","article-title":"Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients","volume":"44","author":"Pedersen","year":"1998","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib134","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/ana.410440419","article-title":"Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis","volume":"44","author":"Smith","year":"1998","journal-title":"Ann. Neurol."},{"issue":"10","key":"10.1016\/j.freeradbiomed.2016.10.490_bib135","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1212\/WNL.62.10.1758","article-title":"Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden","volume":"62","author":"Simpson","year":"2004","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.freeradbiomed.2016.10.490_bib136","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1046\/j.1471-4159.1997.69052064.x","article-title":"Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis","volume":"69","author":"Ferrante","year":"1997","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.freeradbiomed.2016.10.490_bib137","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1098-1136(199802)22:2<149::AID-GLIA6>3.0.CO;2-2","article-title":"4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes","volume":"22","author":"Blanc","year":"1998","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.freeradbiomed.2016.10.490_bib138","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tins.2003.11.001","article-title":"Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis","volume":"27","author":"Rao","year":"2004","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.10.490_bib139","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1523\/JNEUROSCI.23-07-02627.2003","article-title":"Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons","volume":"23","author":"Rao","year":"2003","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.freeradbiomed.2016.10.490_bib140","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.freeradbiomed.2004.12.021","article-title":"Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis","volume":"38","author":"Perluigi","year":"2005","journal-title":"Free Radic. Biol. Med."},{"issue":"4","key":"10.1016\/j.freeradbiomed.2016.10.490_bib141","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.freeradbiomed.2005.03.030","article-title":"Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis","volume":"39","author":"Poon","year":"2005","journal-title":"Free Radic. Biol. Med."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916309807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584916309807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:52:50Z","timestamp":1760205170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584916309807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":141,"alternative-id":["S0891584916309807"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.10.490","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.10.490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}